UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan · Delayed Price · Currency is TWD 62.50
+0.50 (0.81%)
Jul 22, 2025, 1:03 PM CST
UnicoCell Biomed Company Description
UnicoCell Biomed Co., Ltd. engages in the research and development of stem cell drugs, cell therapy technology, and regenerative medical services in Taiwan.
It develops ELIXCYTE, which is in Phase 2 clinical trials for the treatment of osteoarthritis and chronic kidney disease.
The company offers UnicoVial, a cryotube and drug container for cell therapy products, as well as provides testing services.
UnicoCell Biomed Co., Ltd. is based in Taipei, Taiwan.
UnicoCell Biomed Co., Ltd.
| Country | Taiwan |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Yi-Pei Hung |
Contact Details
Address: No. 13-20, Minquan East Road Taipei, 11494 Taiwan | |
| Phone | 886 2 2792 2699 |
| Website | unicocell.com |
Stock Details
| Ticker Symbol | 6794 |
| Exchange | Taiwan Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Yi-Pei Hung | Chief Executive Officer |